Aldevron News

PTC Therapeutics Establishes Strategic Collaboration with Aldevron to Support GMP Plasmid Manufacturing

PTC_News-1PTC Therapeutics, Inc., is collaborating with Aldevron to secure GMP manufacturing capacity for PTC's gene therapy portfolio. This portfolio includes the Friedreich ataxia and Angelman syndrome programs in PTC's gene therapy pipeline.

The agreement represents an ongoing dedication to deliver best-in-class gene therapies to patients in need.

Topics: Gene Therapy, Plasmid DNA, Clinical Grade Manufacturing/cGMP, Partnerships